Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 461

1.

MiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study.

Muti P, Donzelli S, Sacconi A, Hossain A, Ganci F, Frixa T, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G.

Carcinogenesis. 2017 Nov 4. doi: 10.1093/carcin/bgx126. [Epub ahead of print]

PMID:
29126102
2.

[Mediterranean diet for everyone].

Berrino F.

Epidemiol Prev. 2017 Sep-Dec;41(5-6):225. doi: 10.19191/EP17.5-6.P225.076. Italian. No abstract available.

PMID:
29119751
3.

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Epub 2017 Sep 1.

PMID:
28865261
4.

"Open mesh" or "strictly selected population" recruitment? The experience of the randomized controlled MeMeMe trial.

Cortellini M, Berrino F, Pasanisi P.

Patient Prefer Adherence. 2017 Jul 6;11:1127-1132. doi: 10.2147/PPA.S135412. eCollection 2017.

5.

Nut intake and 5-year changes in body weight and obesity risk in adults: results from the EPIC-PANACEA study.

Freisling H, Noh H, Slimani N, Chajès V, May AM, Peeters PH, Weiderpass E, Cross AJ, Skeie G, Jenab M, Mancini FR, Boutron-Ruault MC, Fagherazzi G, Katzke VA, Kühn T, Steffen A, Boeing H, Tjønneland A, Kyrø C, Hansen CP, Overvad K, Duell EJ, Redondo-Sánchez D, Amiano P, Navarro C, Barricarte A, Perez-Cornago A, Tsilidis KK, Aune D, Ward H, Trichopoulou A, Naska A, Orfanos P, Masala G, Agnoli C, Berrino F, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Ericson U, Sonestedt E, Winkvist A, Braaten T, Romieu I, Sabaté J.

Eur J Nutr. 2017 Jul 21. doi: 10.1007/s00394-017-1513-0. [Epub ahead of print]

PMID:
28733927
6.

Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, Campagnoli C, Berrino F, Fanciulli M, Ford RJ, Levrero M, Pediconi N, Ciuffreda L, Milella M, Steinberg GR, Cioce M, Muti P, Strano S, Blandino G.

Cell Discov. 2017 Jul 4;3:17022. doi: 10.1038/celldisc.2017.22. eCollection 2017.

7.

Geographical variability in survival of European children with central nervous system tumours.

Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6.

PMID:
28689091
8.

Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404].

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Dec;147(3):725. doi: 10.1016/j.ygyno.2017.06.033. Epub 2017 Jul 5. No abstract available.

PMID:
28688523
9.

Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413].

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; CONCORD Working Group; Africa.

Gynecol Oncol. 2017 Dec;147(3):726. doi: 10.1016/j.ygyno.2017.06.032. Epub 2017 Jul 5. No abstract available.

PMID:
28687170
10.

[What can I eat, doc?]

Berrino F.

Epidemiol Prev. 2017 Mar-Apr;41(2):79. doi: 10.19191/EP17.2.P79.037. Italian. No abstract available.

11.

Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group.

Lancet Haematol. 2017 May;4(5):e202-e217. doi: 10.1016/S2352-3026(17)30052-2. Epub 2017 Apr 11.

12.

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group.

Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.

PMID:
28410490
13.

A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome.

Pasanisi P, Gargano G, Di Mauro MG, Cortellini M, Casagrande A, Villarini A, Bruno E, Roveda E, Saibene G, Venturelli E, Berrino F.

Tumori. 2017 Jan 20:0. doi: 10.5301/tj.5000599. [Epub ahead of print]

14.

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726.

PMID:
27931752
15.

Effect of aerobic exercise intervention on markers of insulin resistance in breast cancer women.

Bruno E, Roveda E, Vitale J, Montaruli A, Berrino F, Villarini A, Venturelli E, Gargano G, Galasso L, Caumo A, Carandente F, Pasanisi P.

Eur J Cancer Care (Engl). 2016 Dec 7. doi: 10.1111/ecc.12617. [Epub ahead of print]

PMID:
27925359
16.

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725.

PMID:
27919574
17.

European Code against Cancer 4th Edition: Alcohol drinking and cancer.

Scoccianti C, Cecchini M, Anderson AS, Berrino F, Boutron-Ruault MC, Espina C, Key TJ, Leitzmann M, Norat T, Powers H, Wiseman M, Romieu I.

Cancer Epidemiol. 2016 Dec;45:181-188. doi: 10.1016/j.canep.2016.09.011. Epub 2016 Nov 2.

18.

Protective Effect of Aerobic Physical Activity on Sleep Behavior in Breast Cancer Survivors.

Roveda E, Vitale JA, Bruno E, Montaruli A, Pasanisi P, Villarini A, Gargano G, Galasso L, Berrino F, Caumo A, Carandente F.

Integr Cancer Ther. 2017 Mar;16(1):21-31. doi: 10.1177/1534735416651719. Epub 2016 Jun 1.

PMID:
27252076
19.

Community-based participatory research to improve life quality and clinical outcomes of patients with breast cancer (DianaWeb in Umbria pilot study).

Villarini M, Lanari C, Nucci D, Gianfredi V, Marzulli T, Berrino F, Borgo A, Bruno E, Gargano G, Moretti M, Villarini A.

BMJ Open. 2016 Jun 1;6(6):e009707. doi: 10.1136/bmjopen-2015-009707.

20.

Impact of Screening on Breast Cancer Mortality-Letter.

Berrino F.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):872. doi: 10.1158/1055-9965.EPI-16-0014. No abstract available.

Supplemental Content

Loading ...
Support Center